Security
CTT PHARMACEUTICAL HLDGS INC Common Stock · CTTH
CTTHOTCCommon stockCurrentCIK 1035422Updated Nov 9, 2026
Name history
Mindesta Inc. · through Jul 21, 2015INDUSTRIAL MINERALS INC · through Jul 18, 2011PNW CAPITAL INC · through May 21, 2002WINCHESTER MINING CORP · through May 26, 2000
CTTH price & chart
Loading TradingView…
OTC:CTTH on TradingView ↗About the company
CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in oral drug delivery systems designed to provide rapid onset, enhanced patient convenience, and efficient absorption. The Company’s patented micelle based thin film platform is intended to offer a novel alternative to traditional dosage forms across pharmaceutical, therapeutic, and nutraceutical markets. CTT is focused on integrating scientific validation, scalable manufacturing, and regulatory preparedness to support long-term growth and product innovation.
In the news
No coverage from other publishers is available.
Recent filings
4 filing
Other Events
Items 8.01, 9.01
4 filing
4 filing
8-A12G filing
Show 5 more recent filings
Changes in Registrant's Certifying Accountant
Items 4.01, 9.01
Changes in Registrant's Certifying Accountant
Items 4.01, 9.01
4 filing
4/A filing
4 filing
Financials
FY 2014 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2015 | Q3 2014 | Q2 2026 | Q2 2025 | Q2 2015 | Q2 2014 | Q1 2015 | Q1 2014 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 922,038Source | 130,748Source | 67,434Source | — | 1,183,260Source | 227,543Source | 1,418,850Source | 17,219Source | 1,662,370Source | 6,252Source | 203,079Source | 4,182,995Source |
| Property, Plant and Equipment, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 32,121Source | 125,318Source | — | — | 46,073Source | 3,669Source | 73,447Source | 4,545Source | 81,179Source | 823Source | 12,091Source | 569,378Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 5,430Source | — | — | — | 5,430Source | — | 5,430Source | — | 5,430Source | — | — | — |
| Assets, CurrentUSD | 922,038Source | — | 31Source | — | 958,688Source | — | 1,042,002Source | — | 1,049,734Source | 6,252Source | 203,079Source | 750,734Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 183,960Source | 124,600Source | — | — | 156,373Source | 141,987Source | 211,696Source | 279,868Source | 169,490Source | 249,378Source | 589,413Source | 3,726,545Source |
| Commitments and ContingenciesUSD | — | — | — | — | — | 0Source | — | — | — | 0Source | — | — |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 2,132Source | 18,436Source | 5,973Source | — | 2,132Source | 21,395Source | 1,951Source | 18,817Source | 1,951Source | 18,817Source | 18,817Source | 18,592Source |
| Additional Paid in CapitalUSD | 1,951,798Source | 131,982Source | 7,671,441Source | — | 1,951,798Source | 12,944,924Source | 145,729Source | 12,673,369Source | 145,729Source | 12,663,857Source | 12,626,129Source | 12,537,316Source |
| Retained Earnings (Accumulated Deficit)USD | -1,909,002Source | -231,478Source | -7,651,371Source | — | -1,567,071Source | — | -1,204,414Source | — | -867,362Source | — | — | — |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 3,832Source | -3,131Source | — | — | 1,298Source | — | 2,301Source | — | -1,069Source | 0Source | 4,984Source | -105,985Source |
| Stockholders' Equity Attributable to ParentUSD | 738,078Source | 6,148Source | 26,043Source | 82,139Source | 1,026,887Source | 85,556Source | 1,207,154Source | -262,649Source | 1,492,880Source | -243,126Source | -386,334Source | 456,450Source |
| Liabilities and EquityUSD | 922,038Source | 130,748Source | 67,434Source | — | 1,183,260Source | 227,543Source | 1,418,850Source | 17,219Source | 1,662,370Source | 6,252Source | 203,079Source | 4,182,995Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | — | — | 41,391Source | — | — | — | — | — | — | 249,378Source | 589,413Source | 3,726,545Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Additional Financial Items | ||||||||||||
| Dividends Payable, CurrentUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 3,274,072Source |
| Intangible Assets, Net (Excluding Goodwill) | — | — | —Source | — | — | — | — | — | — | — | — | — |
| Preferred Stock, Value, Issued | — | — | —Source | — | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2014 | Q3 2015 | Q3 2014 | Q2 2026 | Q2 2025 | Q2 2015 | Q2 2014 | Q1 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | — | — | — | — | — | — | — | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | 43,650Source | 308,439Source | 0Source | 42,268Source | 155,396Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | — | -39,652Source | -72,250Source | -136,229Source | -1,027,011Source | -316,132Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -147,689Source | — | 151,891Source | 124,961Source | 435,974Source | 877,007Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | — | 28,550Source | — | 0Source | 33,750Source | -37,688Source |
| Additional Financial Items | ||||||||||||
| Deconsolidation, Gain (Loss), AmountUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 6,035,839Source |
| Dividends Payable, CurrentUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 3,274,072Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | 2,846Source | — | — | -7,700Source | -6,206Source | -19,021Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | -25,004Source | — | — | — | 0Source | 0Source |
| General and Administrative ExpenseUSD | — | 14,934Source | 12,946Source | — | — | 4,466Source | 916Source | 34,882Source | 17,641Source | -160,382Source | 158,353Source | 316,408Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | 0Source | -1,518,789Source |
| Net Income (Loss) Attributable to ParentUSD | — | -341,930Source | -43,196Source | — | — | -362,657Source | -920Source | -337,052Source | -672,162Source | 110,464Source | -1,003,188Source | 3,738,515Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Operating ExpensesUSD | — | 341,930Source | 43,196Source | — | — | 362,657Source | 920Source | 337,052Source | 672,162Source | -92,201Source | 1,194,907Source | 757,935Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | 0Source | 33,750Source | 101,250Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | —Source | —Source | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2014 | Q3 2015 | Q3 2014 | Q2 2015 | Q2 2014 | Q1 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | — | — | -22,322Source | -337,052Source | -672,162Source | 92,201Source | -1,194,907Source | -757,935Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | -341,930Source | -43,196Source | -362,657Source | -920Source | -337,052Source | -672,162Source | 110,464Source | -1,003,188Source | 3,738,515Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.01Source | — | 0Source | — | — | 0.01Source | -0.11Source | 0.42Source |
| Earnings Per Share, DilutedUSD per share | — | — | — | — | 0Source | — | — | 0.01Source | -0.11Source | 0.4Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | — | — | 22,346,611Source | — | — | 9,413,581Source | 9,412,659Source | 8,920,635Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | — | — | 22,346,611Source | — | — | 9,413,581Source | 9,412,659Source | 9,492,485Source |
| Additional Financial Items | ||||||||||
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | — | — | — | 0Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | 2,846Source | — | — | -7,700Source | -6,206Source | -19,021Source |
| General and Administrative ExpenseUSD | — | 14,934Source | 12,946Source | 4,466Source | 916Source | 34,882Source | 17,641Source | -160,382Source | 158,353Source | 316,408Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | — | — | — | — | — | 0Source | -1,518,789Source |
| Interest and Other IncomeUSD | — | — | — | — | 0Source | — | — | 1,645Source | 53Source | 6,671Source |
| Marketing and Advertising ExpenseUSD | — | 320Source | — | -610Source | — | 1,006Source | 126,760Source | — | — | — |
| Operating ExpensesUSD | — | 341,930Source | 43,196Source | 362,657Source | 920Source | 337,052Source | 672,162Source | -92,201Source | 1,194,907Source | 757,935Source |
Offerings
Registration 333-292497
Filing attachments
ex99-1.htm · 8-K · 2026-08-12
EX-99.1 2 ex99-1.htm PRESS RELEASE Exhibit 99.1 CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology NEWSWIRE - August 10, 2026 - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the company has been formally approved by the U.S. Patent Office for a continuation-in-part (CIP). A continuation-in-part (CIP) patent is a new application that repeats a substantial portion of an earlier “parent” application while adding brand new …
Read attachment ↗ex99-1.htm · S-1/A · 2026-05-29
Exhibit 99.1 Weighted Average Shares Outstanding Calculation The weighted average shares outstanding were calculated by applying each stock issuance or cancellation on its effective date and weighting the resulting outstanding shares by the number of days each balance was outstanding during the year. For 2025, the calculation assumes no changes occurred after December 29, 2025, based on the transfer report. Year Ended December 31, 2024 Beginning shares outstanding, January 1, 2024: 51,392,38…
Read attachment ↗